AII
COLL icon

AGF Investments Inc’s Collegium Pharmaceutical COLL Stock Holding History

AGF Investments Inc’s Portfolio COLL Stock Details COLL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q3 		– Sell
-111,509
Closed -$1.32M – 467
2016
Q2 		$1.32M Sell
111,509
-33,491
-23% -$553K 0.01% 286
2016
Q1 		$2.63M Buy
+145,000
New +$2.64M 0.03% 250

Other funds holding COLL

EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return
FM
Frazier Management Seattle, Washington $1.12M AUM 151.58% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
HM
HealthCor Management New York $109M AUM 10.64% 1-Year Est. Return
TGHSA
TPG Group Holdings (SBS) Advisors Fort Worth, Texas $10.1B AUM 22.58% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
SAM
Sectoral Asset Management Montreal, Quebec, Canada $121M AUM 73.47% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

AGF Investments Inc's COLL Position: Q3 2016 in Review

AGF Investments Inc sold out of Collegium Pharmaceutical (COLL) in Q3 2016, closing a stake of 111,509 shares — an estimated $1.32M sold.

AGF Investments Inc first reported a position in COLL in Q1 2016 and held it in 2 quarters. The position peaked at $2.63M in Q1 2016. 71 funds tracked by Wall St. Rank hold COLL as of Q3 2016.

  • AGF Investments Inc reported no remaining Collegium Pharmaceutical position as of Q3 2016 after selling out during the quarter.
  • AGF Investments Inc sold 111,509 Collegium Pharmaceutical shares in Q3 2016, an estimated $1.32M.
  • AGF Investments Inc first reported a position in Collegium Pharmaceutical in Q1 2016 and held it in 2 quarters.
  • AGF Investments Inc's Collegium Pharmaceutical position peaked at $2.63M in Q1 2016.
  • 71 funds tracked by Wall St. Rank held Collegium Pharmaceutical as of Q3 2016.

Based on AGF Investments Inc's 13F filing for Q3 2016, filed 24 Oct 2016.